MUTYH-associated Polyposis Syndrome

Overview


Plain-Language Overview

MUTYH-associated Polyposis Syndrome is a genetic condition that affects the colon and rectum, leading to the development of many small growths called polyps. These polyps are benign at first but can turn into colorectal cancer if not monitored or treated. The syndrome is caused by changes in a gene responsible for repairing DNA damage, which increases the risk of abnormal cell growth. People with this condition often develop dozens to hundreds of polyps, usually starting in adulthood. Early detection and regular screening are important because the condition significantly raises the chance of developing colon cancer over time.

Clinical Definition

MUTYH-associated Polyposis Syndrome (MAP) is an autosomal recessive hereditary colorectal cancer syndrome characterized by the development of multiple adenomatous polyps in the colon and rectum. It results from biallelic mutations in the MUTYH gene, which encodes a DNA glycosylase involved in base excision repair of oxidative DNA damage. The defective repair mechanism leads to accumulation of G:C to T:A transversions, promoting oncogenic mutations. Clinically, MAP presents with 10 to several hundred adenomatous polyps, typically fewer than seen in familial adenomatous polyposis (FAP), and an increased lifetime risk of colorectal cancer often by the 5th or 6th decade. Extra-colonic manifestations are less common than in FAP. The syndrome is significant due to its cancer predisposition and the need for genetic counseling and surveillance.

Inciting Event

Locked content

Latency Period

Locked content

Diagnostic Delay

Locked content

Clinical Presentation


Signs & Symptoms

Locked content

History of Present Illness

Locked content

Past Medical History

Locked content

Family History

Locked content

Physical Exam Findings

Locked content

Diagnostic Workup


Diagnostic Criteria

Locked content

Pathophysiology


Key Mechanisms

Locked content

Organs

Locked content

Tissues

Locked content

Cells

Locked content

Chemical Mediators

Locked content

Treatments


Pharmacological Treatments

Locked content

Non-pharmacological Treatments

Locked content

Prevention


Pharmacological Prevention

Locked content

Non-pharmacological Prevention

Locked content

Outcome & Complications


Complications

Locked content

Short-term Sequelae

Locked content

Long-term Sequelae

Locked content

Differential Diagnoses


Differentials

Locked content

Medical Disclaimer: The content on this site is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. If you think you may be experiencing a medical emergency, call 911 or your local emergency number immediately. Always consult a licensed healthcare professional with questions about a medical condition.

Artificial Intelligence Use: Portions of this site’s content were generated or assisted by AI and reviewed by Erik Romano, MD; however, errors or omissions may occur.

USMLE® is a registered trademark of the Federation of State Medical Boards (FSMB) and the National Board of Medical Examiners (NBME). Doctogenic and Roscoe & Romano are not affiliated with, sponsored by, or endorsed by the USMLE, FSMB, or NBME. Neither FSMB nor NBME has reviewed or approved this content. "USMLE Step 1" and "USMLE Step 2 CK" are used only to identify the relevant examinations.